Novel Aptamers for Diagnosis and Therapy of Human Glioblastoma

We offer novel high affinity aptamer sequences that target the zinc finger motif of the glioblastoma oncogene protein. The specificity of aptamers to different zinc finger transcription factors, which are to a large extend involved in human diseases, has the potential for valuable new agents for diagnostic and therapeutic application.

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Ursula Haufe

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Neurons: How RNA granules grow and shrink

LMU scientists have shown that small aggregates function as temporary RNA repositories, which are regulated by neural activity. Cells constantly have to adapt the level of activity of certain genes…

Custom ‘headphones’ boost atomic radio reception 100-fold

Researchers at the National Institute of Standards and Technology (NIST) have boosted the sensitivity of their atomic radio receiver a hundredfold by enclosing the small glass cylinder of cesium atoms…

New tech aims to drive down costs of hydrogen fuel

Researchers from North Carolina State University have developed a new technique for extracting hydrogen gas from liquid carriers which is faster, less expensive and more energy efficient than previous approaches….

Partners & Sponsors